Principal Financial Group Inc Bio Rad Laboratories, Inc. Transaction History

Principal Financial Group Inc

  • $162 Billion
  • Q1 2024

A detailed history of Principal Financial Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 27,055 shares of BIO stock, worth $7.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,055
Previous 26,977 0.29%
Holding current value
$7.49 Million
Previous $8.71 Million 7.43%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$304.11 - $351.99 $23,720 - $27,455
78 Added 0.29%
27,055 $9.36 Million
Q4 2023

Feb 07, 2024
SELL
$269.37 - $365.04 $160,275 - $217,198
-595 Reduced 2.16%
26,977 $8.71 Million
Q3 2023

Nov 02, 2023
SELL
$350.25 - $422.63 $128,892 - $155,527
-368 Reduced 1.32%
27,572 $9.88 Million
Q2 2023

Aug 07, 2023
SELL
$359.49 - $486.4 $896,208 - $1.21 Million
-2,493 Reduced 8.19%
27,940 $10.6 Million
Q1 2023

May 09, 2023
BUY
$418.69 - $503.0 $127,281 - $152,912
304 Added 1.01%
30,433 $14.6 Million
Q4 2022

Feb 09, 2023
BUY
$351.71 - $456.01 $697,792 - $904,723
1,984 Added 7.05%
30,129 $12.7 Million
Q3 2022

Nov 09, 2022
SELL
$412.59 - $563.26 $7.44 Million - $10.2 Million
-18,038 Reduced 39.06%
28,145 $11.7 Million
Q2 2022

Aug 10, 2022
BUY
$463.67 - $597.16 $102,471 - $131,972
221 Added 0.48%
46,183 $22.9 Million
Q1 2022

May 09, 2022
SELL
$524.57 - $735.42 $4.89 Million - $6.85 Million
-9,318 Reduced 16.86%
45,962 $25.9 Million
Q4 2021

Feb 09, 2022
SELL
$708.84 - $794.68 $747,826 - $838,387
-1,055 Reduced 1.87%
55,280 $41.8 Million
Q3 2021

Nov 09, 2021
BUY
$657.71 - $825.77 $515,644 - $647,403
784 Added 1.41%
56,335 $42 Million
Q2 2021

Aug 10, 2021
SELL
$576.64 - $649.04 $1.78 Million - $2 Million
-3,084 Reduced 5.26%
55,551 $35.8 Million
Q1 2021

May 10, 2021
BUY
$547.01 - $662.35 $16.1 Million - $19.5 Million
29,513 Added 101.34%
58,635 $33.5 Million
Q4 2020

Feb 08, 2021
SELL
$510.68 - $643.45 $1.14 Million - $1.43 Million
-2,228 Reduced 7.11%
29,122 $17 Million
Q3 2020

Nov 06, 2020
SELL
$454.43 - $535.6 $807,522 - $951,761
-1,777 Reduced 5.36%
31,350 $16.2 Million
Q2 2020

Aug 05, 2020
SELL
$334.87 - $493.06 $11.3 Million - $16.7 Million
-33,837 Reduced 50.53%
33,127 $15 Million
Q1 2020

May 12, 2020
SELL
$320.01 - $409.07 $8.88 Million - $11.4 Million
-27,748 Reduced 29.3%
66,964 $23.5 Million
Q4 2019

Feb 05, 2020
BUY
$319.73 - $374.2 $295,110 - $345,386
923 Added 0.98%
94,712 $35 Million
Q3 2019

Nov 13, 2019
BUY
$304.55 - $345.24 $1.67 Million - $1.9 Million
5,492 Added 6.22%
93,789 $31.2 Million
Q2 2019

Aug 12, 2019
SELL
$286.93 - $312.59 $121,084 - $131,912
-422 Reduced 0.48%
88,297 $27.6 Million
Q1 2019

May 10, 2019
SELL
$224.3 - $317.41 $213,309 - $301,856
-951 Reduced 1.06%
88,719 $27.1 Million
Q4 2018

Feb 14, 2019
SELL
$220.1 - $309.0 $287,670 - $403,863
-1,307 Reduced 1.44%
89,670 $20.8 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $277,419 - $312,777
959 Added 1.07%
90,977 $28.5 Million
Q2 2018

Aug 13, 2018
BUY
$244.1 - $303.88 $410,576 - $511,126
1,682 Added 1.9%
90,018 $0
Q1 2018

May 14, 2018
BUY
$233.97 - $274.11 $497,654 - $583,031
2,127 Added 2.47%
88,336 $22.1 Million
Q4 2017

Feb 13, 2018
SELL
$216.94 - $271.3 $66,383 - $83,017
-306 Reduced 0.35%
86,209 $20.6 Million
Q3 2017

Nov 02, 2017
BUY
$212.27 - $242.28 $18.4 Million - $21 Million
86,515
86,515 $19.2 Million

Others Institutions Holding BIO

# of Institutions
489
Shares Held
17.8M
Call Options Held
44.9K
Put Options Held
79.7K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.82B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email